RECRUITING

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this research study the investigators will use sleep headbands to measure brain rhythms and to improve their coordination across brain regions. The headbands will be worn at home for multiple nights. On some nights the headbands will play soft sounds at specific times during sleep. The investigators are interested in learning whether this timed auditory stimulation may be a strategy to improve the coordination of sleep rhythms across brain regions, improve network communication, and as a result, improve memory. The investigators will study 30 adults aged 18-45 with schizophrenia and 30 demographically matched healthy controls. Participants will first have a daytime MRI scan, during which they will complete a finger tapping motor sequence task (MST), followed by a week of sleep at home with a sleep headband. They will also do the MST at home on two of the nights. On the final day of the study, participants will return for a second MRI scan.

Official Title

The Effects of Auditory Stimulation During Sleep on Offline Learning and Thalamocortical-hippocampal Connectivity in Schizophrenia

Quick Facts

Study Start:2025-02-05
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06386588

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-45 years old
  2. * Fluent in English
  3. * Able to give informed consent
  4. * A DSM-V confirmed diagnosis of schizophrenia
  5. * Unmedicated or maintained on a stable dose of APDs
  1. * Ferrous metal in the body
  2. * Currently pregnant or breastfeeding
  3. * Motor problems that preclude finger tapping task
  4. * IQ \<85
  5. * Other neurological disorders, including seizure disorder
  6. * Significant hearing or vision loss
  7. * Chronic medical conditions that affect sleep
  8. * Unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, or cardiac disease
  9. * Diagnosed sleep disorder, except insomnia
  10. * History of head injury resulting in prolonged loss of consciousness or other neurological sequelae
  11. * History of mental illness
  12. * Current use of psychotropic medications or treatment with medications known to affect sleep or cognition

Contacts and Locations

Study Contact

Lindsey Jones, MS
CONTACT
617-702-2368
manoachlab@gmail.com
Dara Manoach, PhD
CONTACT
617-724-6148
dara.manoach@mgh.harvard.edu

Study Locations (Sites)

Massachusetts General Hospital
Charlestown, Massachusetts, 02129
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-05
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2025-02-05
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • Hippocampus
  • Neuromodulation
  • Sleep spindles
  • Thalamocortical circuits
  • Auditory stimulation
  • Magnetic resonance imaging
  • Sleep
  • Memory

Additional Relevant MeSH Terms

  • Schizophrenia